Axiom Investors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,204
| Closed | -$641K | – | 149 |
|
|
2025
Q1 | $641K | Sell |
52,204
-1,020
| -2% | -$12.5K | 0.01% | 131 |
|
|
2024
Q4 | $704K | Sell |
53,224
-62,418
| -54% | -$825K | 0.01% | 130 |
|
|
2024
Q3 | $2.23M | Buy |
115,642
+20,502
| +22% | +$395K | 0.02% | 115 |
|
|
2024
Q2 | $1.95M | Buy |
95,140
+1,075
| +1% | +$22.1K | 0.02% | 119 |
|
|
2024
Q1 | $2.24M | Buy |
94,065
+7,890
| +9% | +$188K | 0.02% | 124 |
|
|
2023
Q4 | $1.86M | Buy |
86,175
+75,355
| +696% | +$1.63M | 0.02% | 121 |
|
|
2023
Q3 | $157K | Sell |
10,820
-19,290
| -64% | -$280K | ﹤0.01% | 132 |
|
|
2023
Q2 | $630K | Buy |
30,110
+1,915
| +7% | +$40.1K | 0.01% | 124 |
|
|
2023
Q1 | $595K | Buy |
+28,195
| New | +$595K | 0.01% | 125 |
|